ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies Developing the first gene therapy to treat diseases caused by cilia dysfunctionAXV101 targets retinal dystrophy for Bardet-Biedl Syndrome (BBS) patientsFDA Orphan Drug Designation and Rare Pediatric...

RadioMedix and Orano Med receive FDA Orphan Drug Designation for AlphaMedix (TM) for the treatment of neuroendocrine tumors Houston (TX U.S.), Courbevoie (France), Nov. 13, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. (a Texas-based clinical stage biotechnology company) and Orano Med (a nuclear biotechnology company)...